-
Admin
Patients who participate in clinical trials – insights into their thinking and desires
Interviews by Marie Lux give great insights on patients: How…
-
Admin
New data on chemotherapy resistance in ovarian cancer
University of Michigan The new study’s author,?J. Rebecca Liu, M.D.,…
-
Admin
Jimmy Carter’s Melanoma drug on the verge of ?breakthrough?
In 2014, FDA gave pembrolizumab accelerated approval for melanoma.? Today,…
-
Admin
Why synthesize the human genome? Easier pathways for medical research??
Update to previous report (@NYTScience)?of scientists meeting at?Harvard Medical School…
-
Admin
New PhRMA-commissioned report on US biopharmaceutical sector
New PhRMA-commissioned report: The US biopharmaceutical sector supports ~4.5 million…
Latest Posts
Categories
- Best Practices
- Change Management
- Clinical
- Clinical Trials
- Collaboration
- Communication
- Complexity
- Governance
- International Clinical Trials Day
- Leadership
- Marketing
- Medical Education
- MSL
- Patient-centered
- Pharma News
- PMOs
- Portfolio Management
- Program Management
- Project Management
- Project Management Salaries
- Project/Program/Portfolio Management
- Recruiting
- Salaries
- Uncategorized
Tags
3SixtyPharma Alzheimer's Anti-IgE anti-inflammatory anti-TNF anti-TNF-? B-cell Biosimilar clinical clinical research CNS Communication CT-P13 DEMENTIA FDA gastrointestinal genome GI Inflammation Inflectra infliximab interchangeability investigational JAK inhibitor KTE-C19 Lymphoma oncology patients Pharma Portfolio Management Program Management Project Management rare disease remote Remsima rheumatoid arthritis spondyloarthritis switching Theravance Biopharma virtual w webinar White House White House Office of Management and Budget White House OMB